Haemonetics Corp
HAENYSECIK 313143HealthcareFiscal year ends Apr 3
Reports and events: 277 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0810:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000313143-26-000138 |
| 2026-08-1810:03 ET | 8-K | 7.01 Regulation FD disclosure | 0000313143-26-000135 |
| 2026-08-0610:09 ET | 10-Q | Quarterly reportPeriod 2026-06-27 | 0000313143-26-000120 |
| 2026-08-0610:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-26-000118 |
| 2026-07-2820:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000313143-26-000095 |
| 2026-06-0920:17 ET | DEF 14A | Proxy statementPeriod 2026-03-28 | 0000313143-26-000074 |
| 2026-06-0510:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000313143-26-000057 |
| 2026-05-2010:31 ET | 10-K | Annual reportPeriod 2026-03-28 | 0000313143-26-000050 |
| 2026-05-0710:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-26-000031 |
| 2026-05-0120:18 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000313143-26-000023 |
| 2026-03-0311:09 ET | 8-K | 7.01 Regulation FD disclosure | 0000313143-26-000017 |
| 2026-02-1221:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000313143-26-000014 |
| 2026-02-0511:05 ET | 10-Q | Quarterly reportPeriod 2025-12-27 | 0000313143-26-000010 |
| 2026-02-0511:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-26-000009 |
| 2026-01-0911:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000313143-26-000003 |
| 2025-11-0611:03 ET | 10-Q | Quarterly reportPeriod 2025-09-27 | 0000313143-25-000075 |
| 2025-11-0611:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-25-000074 |
| 2025-08-0710:08 ET | 10-Q | Quarterly reportPeriod 2025-06-28 | 0000313143-25-000058 |
| 2025-08-0710:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-25-000056 |
| 2025-07-2520:16 ET | 8-K | 5.07 Shareholder vote results | 0000313143-25-000047 |
| 2025-06-0620:17 ET | DEF 14A | Proxy statementPeriod 2025-03-29 | 0000313143-25-000041 |
| 2025-05-2110:12 ET | 10-K | Annual reportPeriod 2025-03-29 | 0000313143-25-000025 |
| 2025-05-0810:03 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000313143-25-000021 |
| 2025-03-0321:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000313143-25-000015 |
| 2025-02-0611:20 ET | 10-Q | Quarterly reportPeriod 2024-12-28 | 0000313143-25-000012 |
| 2025-02-0611:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-25-000011 |
| 2025-01-1411:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000313143-25-000006 |
| 2025-01-0311:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000313143-25-000003 |
| 2024-12-0311:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000313143-24-000066 |
| 2024-11-0711:11 ET | 10-Q | Quarterly reportPeriod 2024-09-28 | 0000313143-24-000063 |
| 2024-11-0711:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-24-000060 |
| 2024-09-1620:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000313143-24-000056 |
| 2024-08-0810:05 ET | 10-Q | Quarterly reportPeriod 2024-06-29 | 0000313143-24-000054 |
| 2024-08-0810:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-24-000053 |
| 2024-07-3020:23 ET | 8-K/A | 5.07 Shareholder vote results | 0000313143-24-000047 |
| 2024-07-2520:10 ET | 8-K | 5.07 Shareholder vote results | 0000313143-24-000044 |
| 2024-06-0710:26 ET | DEF 14A | Proxy statementPeriod 2024-03-30 | 0000313143-24-000040 |
| 2024-05-2920:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-066056 |
| 2024-05-2310:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-064437 |
| 2024-05-2120:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-063835 |
| 2024-05-2010:16 ET | 10-K | Annual reportPeriod 2024-03-30 | 0000313143-24-000020 |
| 2024-05-0910:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-24-000015 |
| 2024-05-0120:12 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950103-24-006128 |
| 2024-04-0112:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000313143-24-000012 |
| 2024-03-0511:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000313143-24-000009 |
| 2024-02-0811:06 ET | 10-Q | Quarterly reportPeriod 2023-12-30 | 0000313143-24-000007 |
| 2024-02-0811:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-24-000006 |
| 2023-12-1211:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000313143-23-000060 |
| 2023-11-0210:19 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000313143-23-000057 |
| 2023-11-0210:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-23-000056 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.